Skip to content
Information needed? Call us at +31 412 700 501|services@oncolines.com
Oncolines B.V. Logo Oncolines B.V. Logo Oncolines B.V. Logo
  • Home
  • About
    • About Oncolines®
    • Technology Platforms
    • Case Studies
    • Our Team
    • Vacancies
    • www.residencetimer.com
  • Services
    • Oncolines®
      • Oncolines® Profiling Explained
      • Proliferation Assays
        • Oncolines® Cancer Cell Lines
      • Bioinformatics Analysis
        • Gene Mutation Analysis
        • Tissue Sensitivity Analysis
        • Gene Expression Analysis
        • Comparative Analysis
    • SynergyFinder™
      • Drug Combination Studies
      • Combination Studies Explained
    • Mechanistic Cell Biology
      • Proof of Concept Studies
  • News
    • News
    • Publications
  • FAQ
  • Contact
  • Home
  • About
    • About Oncolines®
    • Technology Platforms
    • Case Studies
    • Our Team
    • Vacancies
    • www.residencetimer.com
  • Services
    • Oncolines®
      • Oncolines® Profiling Explained
      • Proliferation Assays
        • Oncolines® Cancer Cell Lines
      • Bioinformatics Analysis
        • Gene Mutation Analysis
        • Tissue Sensitivity Analysis
        • Gene Expression Analysis
        • Comparative Analysis
    • SynergyFinder™
      • Drug Combination Studies
      • Combination Studies Explained
    • Mechanistic Cell Biology
      • Proof of Concept Studies
  • News
    • News
    • Publications
  • FAQ
  • Contact
  • Home
  • About
    • About Oncolines®
    • Oncolines® Technology Platforms
    • Case Studies
    • Oncolines® – Team
    • Vacancies
    • www.residencetimer.com
  • Services
    • Oncolines®
      • Oncolines® Profiling Explained
      • Proliferation assays
        • List of Cancer Cell Lines in the Oncolines® Panel
      • Bioinformatics
        • Gene Mutation Analysis
        • Tissue Sensitivity Analysis
        • Gene Expression Analysis via GeneNominator™
        • Comparative Analysis via OncolinesProfiler™
    • SynergyFinder ™
      • Combination Studies Explained
    • Mechanistic Cell Biology
  • Publications
  • News
  • FAQ
  • Contact
Home/Downloads
DownloadsNTRC Oncolines2019-11-18T17:13:42+01:00

OUR MISSION

Helping to Bring Improved and
Novel Therapies to the Right
Patient Population Faster.

read more

Our other site

For more information about ResidenceTimer™,
please visit our website

www.residencetimer.com

Follow us!

Oncolines B.V.

logo NTRC

Oncolines B.V. is a wholly owned subsidiary of Netherlands Translational Research Center B.V.

+31 412 700 501
© 2021 - Oncolines B.V. - Privacy statement
Page load link
This website uses cookies and third party services. Accept
×

Hi there!

Click on the representative below to chat via WhatsApp

% %
#
Janneke Melis
NTRC Precision Medicine Services Janneke Melis Available on SundayMondayTuesdayWednesdayThursdayFridaySaturday

We will respond to your message as soon as possible, probably within 24 hours.


          
          

            
            
              
            
          

        

      

              
                  
                ×
                        
      

      













		


			

		
			Go to Top